Europe Anesthesia Drugs Market to Witness Steady Growth at 2.4% CAGR During 2018-2023 | Key Players: BAXTER HEALTHCARE, HOSPIRA, ABBOTT LABORATORIES, ASTRA ZENECA, ROCHE HOLDING AG, B. BRAUN MELSUNGEN AG, ABBVIE, BOEHRINGER INGELHEIM

Europe Anesthesia Drugs Market Highlights
The European anesthesia drugs market is expected to register a CAGR of 2.4% during the forecast period (2018 - 2023). Anesthetic is a drug which causes anesthesia, it is a reversible loss of sensation. There are several types of anesthesia drugs available in the market such as the general anesthesia, spinal anesthesia, IV regional anesthesia, local anesthesia, peripheral nerve block, and saddle block or caudal anesthesia, etc.

Get your sample report now @ https://www.marketprognosis.com/sample-request/16917
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Rise in the Number of Surgeries
According to a National Health Service (NHS), in 2013-2014, there were an estimated 4.7 million surgical admissions in England, among all the surgeries, general surgeries, trauma, and orthopedic procedures were the most common ones. The number of surgeries being performed is rising every year. The overall increase in the number of surgeries performed has a strong impact on the anesthetics market, as they are used in all surgical procedures to reduce the pain during surgery. Along with rising surgeries, factors such as new anesthetic drugs are also driving the market.

Key Developments in the Market
• September 2017: AstraZeneca made an agreement with Aspen Global Incorporated (AGI).
• April 2017: B. Braun and Philips joined forces to innovate in ultrasound-guided regional anesthesia and vascular access.

Major Players:
BAXTER HEALTHCARE, HOSPIRA, ABBOTT LABORATORIES, ASTRA ZENECA, ROCHE HOLDING AG, B. BRAUN MELSUNGEN AG, ABBVIE, BOEHRINGER INGELHEIM, EISAI, FRESENIUS SE & CO. KGAA, among others.

Get Discount on this report @ https://www.marketprognosis.com/discount-request/16917
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Side Effects of General Anesthesia
General anesthetic drugs cause several side-effects including nausea, vomiting, dry mouth, sore throat, shivering, muscle aches, disorientation, itching, sleepiness, and mild hoarseness. More serious complications of the drug include delirium, cognitive dysfunction, and malignant hyperthermia. General anesthetic drugs can cause physiological changes such as blood pressure variations which require a trained anesthesiologist to monitor the patient’s blood pressure levels continuously and might have to provide blood pressure medications. Carelessness or lack of knowledge of the anesthesiologist could pose as a potential risk. Hence, the side-effects of general anesthesia and patient’s reluctance towards using it are restraining the segment growth. The other factors such as lack of skilled anesthetics and regulatory issues are restraining the market growth.

General Anesthesia Drugs Segment to dominate the Market
General anesthesia drugs segment has the largest market share in the anesthesia drugs market. The major driving force that accounts for such growth in this segment is the increase in the number of general and emergency surgeries which require the use of general anesthesia drugs.
From the technology point of view, advancements in the development of new general anesthesia drugs are the prime driving force for this growth of the general anesthesia segment.

For More Information, Please Visit @ https://www.marketprognosis.com/enquiry/16917
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.